Document Detail


Improved haemodynamics but reduced arterial blood oxygenation, at rest and during exercise after long-term oral prazosin therapy in chronic cor pulmonale.
MedLine Citation:
PMID:  3938395     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The effect of vasodilator therapy in chronic obstructive lung disease with pulmonary hypertension was evaluated in eight patients during oral prazosin therapy (2-10 mg day-1). After one week, prazosin reduced mean pulmonary artery pressure and pulmonary and systemic vascular resistance, and increased cardiac index both at rest and during exercise. Similarly improved haemodynamics were observed after two months of therapy. Arterial PO2 and oxygen saturation fell significantly after two months both at rest and during exercise, but were not changed after one week. Lung function tests were not altered by prazosin. Thus, although prazosin improves the haemodynamics in patients with chronic obstructive lung disease, caution is advised in long-term therapy since prazosin worsens the arterial blood oxygenation.
Authors:
H Vik-Mo; N Walde; H Jentoft; F J Halvorsen
Related Documents :
3298195 - Relationship between ozone exposure and pulmonary function changes.
453645 - Relationship between response to exercise and allergy in patients with cystic fibrosis.
8436745 - Pulmonary and peripheral vascular factors are important determinants of peak exercise o...
9207705 - Effective physical therapy for chronic obstructive pulmonary disease. pilot study of ex...
23819505 - Thermography applied during exercises with or without infrared light-emitting diode irr...
12378645 - Pancreatic microcirculatory impairment in experimental acute pancreatitis in rats.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European heart journal     Volume:  6     ISSN:  0195-668X     ISO Abbreviation:  Eur. Heart J.     Publication Date:  1985 Dec 
Date Detail:
Created Date:  1986-05-07     Completed Date:  1986-05-07     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  8006263     Medline TA:  Eur Heart J     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  1047-53     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Oral
Aged
Carbon Dioxide / blood
Chronic Disease
Female
Hemodynamics / drug effects*
Humans
Hypertension, Pulmonary / complications
Lung / physiopathology
Lung Diseases, Obstructive / complications
Male
Middle Aged
Oxygen / blood*
Physical Exertion*
Prazosin / administration & dosage,  pharmacology*,  therapeutic use
Pulmonary Heart Disease / drug therapy,  etiology,  physiopathology*
Rest
Chemical
Reg. No./Substance:
124-38-9/Carbon Dioxide; 19216-56-9/Prazosin; 7782-44-7/Oxygen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Metabolism of aromatic amines by prostaglandin H synthase.
Next Document:  Mitomycin C and vinblastine in the treatment of advanced breast cancer.